about bpl

Bio Products Laboratory Ltd.

News

PRESS RELEASE: Creat Group Corporation Completes Acquisition of Bio Products Laboratory Ltd

Elstree, 1 August, 2016 - Bio Products Laboratory Ltd. ("BPL"), a leading plasma biotherapeutics company, today announces that a group controlled by Creat Group Corporation ("Creat"), has finalized the acquisition of BPL.  BPL, headquartered in Elstree, Hertfordshire, provides lifesaving therapeutics for conditions related to immune deficiencies, ...

Date added: Tuesday 2nd August 2016
Latest updated: Wednesday 8th February 2017

PRESS RELEASE - 6 June 2016: Bio Products Laboratory launches Coagadex® ▼ (human coagulation factor X) in the UK Treatment for rare bleeding disorder ‘hereditary factor X deficiency’ and is made available in the UK

ELSTREE, UK Bio Products Laboratory, Limited (BPL) today, announced that Coagadex is now available for patients in the UK. Coagadex is indicated for the treatment and prophylaxis of bleeding episodes and for perioperative management in patients with hereditary factor X deficiency. Coagadex is the ...

Date added: Monday 6th June 2016
Latest updated: Wednesday 8th February 2017

PRESS RELEASE: Creat Group Corporation agrees to acquire Bio Products Laboratory Ltd.

Elstree, 19 May, 2016 – Bio Products Laboratory Ltd. (“BPL”), a leading plasma biotherapeutics company, today announces that a group controlled by Creat Group Corporation (“Creat”), has signed a definitive agreement to acquire the company for a total cash consideration of £820 million. BPL, headquartered in ...

Date added: Thursday 19th May 2016
Latest updated: Wednesday 8th February 2017

PRESS RELEASE: Bio Products Laboratory Receives European Approval for Coagadex® ▼ (Human Coagulation Factor X) First-ever treatment for rare bleeding disorder ‘hereditary factor X deficiency'

NEWS RELEASE: March 17 th 2016     ELSTREE, UK Bio Products Laboratory, Limited (BPL) today announced that the European Medicines Agency has granted marketing authorisation for Coagadex. Coagadex is indicated for the treatment and prophylaxis of bleeding episodes and for ...

Date added: Thursday 17th March 2016
Latest updated: Wednesday 8th February 2017

Patient information leaflets